XJPX4403
Market cap3.33bUSD
Dec 25, Last price
2,196.50JPY
1D
0.05%
1Q
-9.50%
Jan 2017
193.47%
Name
NOF Corp
Chart & Performance
Profile
NOF Corporation manufactures chemicals in Japan. The company operates through Functional Chemicals, Life Science, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, and electronic materials, as well as special corrosion prevention agents. The Life Science segment provides edible oils, functional foods, activated PEG, functional lipids, surfactants for drugs, biocompatible materials, plant-derived ingredients, and MPC polymer/monomer. The Explosive & Propulsion segment offers industrial explosives, solid propellants, pyrotechnic devices, gun propellant/rocket propellant, guided missile assemblies, anti-freezing agents, and temperature and sterilization indicators. It is also involved in logistics, insurance agency, and real estate businesses. The company was founded in 1937 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 222,252,000 2.09% | 217,709,000 13.01% | 192,642,000 11.58% | |||||||
Cost of revenue | 181,030,000 | 177,960,000 | 157,972,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 41,222,000 | 39,749,000 | 34,670,000 | |||||||
NOPBT Margin | 18.55% | 18.26% | 18.00% | |||||||
Operating Taxes | 14,407,000 | 14,025,000 | 11,255,000 | |||||||
Tax Rate | 34.95% | 35.28% | 32.46% | |||||||
NOPAT | 26,815,000 | 25,724,000 | 23,415,000 | |||||||
Net income | 33,990,000 0.05% | 33,973,000 27.29% | 26,690,000 14.54% | |||||||
Dividends | (9,160,000) | (7,916,000) | (6,919,000) | |||||||
Dividend yield | 1.82% | 1.57% | 1.67% | |||||||
Proceeds from repurchase of equity | (7,517,000) | (5,451,000) | (3,869,000) | |||||||
BB yield | 1.50% | 1.08% | 0.93% | |||||||
Debt | ||||||||||
Debt current | 1,860,000 | 2,333,000 | 4,927,000 | |||||||
Long-term debt | 4,088,000 | 2,791,000 | 924,000 | |||||||
Deferred revenue | 6,000 | 5,286,000 | 5,428,000 | |||||||
Other long-term liabilities | 5,182,000 | 224,000 | 211,000 | |||||||
Net debt | (137,038,000) | (137,116,000) | (132,008,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 29,970,000 | 23,333,000 | 27,393,000 | |||||||
CAPEX | (17,748,000) | (6,219,000) | (7,416,000) | |||||||
Cash from investing activities | (14,964,000) | (709,000) | (8,755,000) | |||||||
Cash from financing activities | (17,101,000) | (16,170,000) | (15,312,000) | |||||||
FCF | 2,574,000 | 14,004,000 | 15,814,000 | |||||||
Balance | ||||||||||
Cash | 91,744,000 | 92,520,000 | 85,430,000 | |||||||
Long term investments | 51,242,000 | 49,720,000 | 52,429,000 | |||||||
Excess cash | 131,873,400 | 131,354,550 | 128,226,900 | |||||||
Stockholders' equity | 258,062,000 | 235,247,000 | 209,880,000 | |||||||
Invested Capital | 144,379,600 | 110,372,450 | 98,866,100 | |||||||
ROIC | 21.05% | 24.59% | 24.70% | |||||||
ROCE | 14.25% | 15.80% | 14.55% | |||||||
EV | ||||||||||
Common stock shares outstanding | 240,771 | 244,401 | 247,311 | |||||||
Price | 2,085.50 1.40% | 2,056.66 22.91% | 1,673.33 -13.30% | |||||||
Market cap | 502,127,920 -0.10% | 502,649,761 21.46% | 413,832,916 -13.97% | |||||||
EV | 365,993,920 | 366,358,761 | 282,601,916 | |||||||
EBITDA | 48,161,000 | 46,108,000 | 40,579,000 | |||||||
EV/EBITDA | 7.60 | 7.95 | 6.96 | |||||||
Interest | 129,000 | 80,000 | 60,000 | |||||||
Interest/NOPBT | 0.31% | 0.20% | 0.17% |